Centessa Pharmaceuticals CNTA 深 沪
已收盘 06-24 16:00:00 美东时间
40.50
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 40.50
- 总市值 62.67亿
- 52周最高 40.56
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 13.22
- 委 比 0.00%
- 总股本 1.55亿
- 历史最高 40.56
- 量 比 0
- 振 幅 0.00%
- 历史最低 2.885
- 每 手 1
- 风险率 7.37%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多半年卖了1800亿元，礼来带飞减重市场
文｜《财经》记者 凌馨 研究员 丁宁 编辑 | 王小 替尔泊肽给了礼来寻找下一个增长曲线的底气 2026年8月5日，礼来发布二季度财报...
08-11 11:25
百亿美金并购新狂潮背后
原标题：百亿美金并购新狂潮背后 又一笔百亿美元级并购诞生。 7月6日，Vertex宣布以每股85美元、总价约100亿美元的全现金交易，正式将专注于内分泌罕见病...
07-08 10:19
Record-setting healthcare M&A activity to extend through H2: PwC
Healthcare dealmaking is already at the highest level since the pandemic, and the momentum is expected to continue into H2 2026, driven by looming patent cliffs and consumer demand for areas such as w...
06-26 01:59
礼来完成对Centessa Pharmaceuticals的收购 布局嗜睡症治疗领域
礼来（LLY）完成对临床阶段生物制药企业森特萨制药（CNTA）的收购，聚焦后者的食欲素2受体激动剂管线，发力发作性睡病等觉醒-睡眠障碍、相关神经类疾病的创新疗法...
06-24 20:56
礼来78亿美元收购Centessa Pharma案获高等法院批准
礼来78亿美元收购Centessa制药的交易已获得高等法院批准，扫清核心监管障碍，向落地迈出关键一步。 Centessa股东可获每股38.00美元现金，以及最...
06-23 14:46
Centessa Pharmaceuticals' Proposed $38/Share Acquisition By Eli Lilly Receives High Court Of Justice Of England And Wales Approval
Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage company developing a new class of medicines for the treatment of excessive daytime sleepiness and other neurological conditions, which entered into a definitive agreement on March 31, 2026 relating to its proposed acquisition by Eli Lilly...
06-23 04:08
Acquisition of Centessa by Lilly Approved by the High Court of Justice of England and Wales
Centessa Pharmaceuticals has been approved by the High Court of England and Wales for acquisition by Eli Lilly and Company for $38 per share plus a CVR, totaling approximately $7.8 billion. The transaction is set to close on June 24, 2026, with Centessa ADSs ceasing trading on June 23.
06-22 20:05
礼来的两套BD策略，对中国Biotech的启示
本文系基于公开资料撰写，仅作为信息交流之用，不构成任何投资建议 今年年初，礼来以最高23亿美元收购了Ajax Therapeutics。它的核心资产包括...
06-16 07:28
